Pomalidomide Capsule
Product Images NDC 63850-0132

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 63850-0132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label (Pomalidomide Capsules 1mg 100capsules)

Each capsule contains Pomalidomide 1 mg. The medication should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The warning highlights the potential for human birth defects. Pharmacists are instructed to dispense the enclosed Medication Guide to each patient. The manufacturer is Natco Pharma Limited, located in Parawada, India. The prescription should follow the usual dosage as per prescribing information for dosing and administration.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 1mg 21capsules)

This text provides information about a medicinal capsule containing 1mg of Pomalidomide, with storage instructions for temperature ranges, prescribing details, and a warning regarding potential human birth defects. It also indicates that the medication should be dispensed with a Medication Guide by the pharmacist. The manufacturing details point to Natco Pharma Limited in India, and it includes lot and expiration date information for tracking and quality control purposes.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 2mg 100capsules)

Each capsule contains Pomalidomide 2 mg. The medication should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is essential to follow the prescribing information for dosing and administration. The warning states the potential for human birth defects and advises pharmacists to dispense the enclosed Medication Guide to each patient. The product consists of 100 capsules manufactured by Natco Pharma Limited in India.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 2mg 21capsules)

Each capsule contains Pomalidomide 2 mg. This medication should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The recommended dosage should be as per prescribing information for dosing and administration. This Pomalidomide medication has the warning of potential for human birth defects. Pharmacists should dispense the enclosed Medication Guide to each patient. The capsules are manufactured by Natco Pharma Limited in India. This product has an expiration date of 11/2025 and the NDC code is 63850-0132-1.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 3mg 100capsules)

Each capsule contains Pomalidomide 3 mg. Store at 20°C to 25°C (68°F to 77°F). Excursions permitted to 15°C to 30°C (59°F to 86°F). Usual dosage: see prescribing information for dosing and administration. Warning: potential for human birth defects. Pharmacists should dispense the enclosed Medication Guide to each patient. 100 Capsules Rx Only. Manufactured by Natco Pharma Limited in India. Identifier NDC 63850-0133-2.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 3mg 21capsules)

This text provides important information about a medication containing Pomalidomide in 3 mg capsules. It includes storage instructions, typical dosage guidance, and a warning about potential birth defects. The manufacturer is Natco Pharma Limited based in India, and it mentions a Medication Guide that should be dispensed to each patient. The text also includes a lot number, expiration date, and various identification codes.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 4mg 100capsules)

Each capsule of Pomalidomide contains 4 mg of the active ingredient. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). This prescription medication carries a warning about the potential for human birth defects. The usual dosage should be determined according to the prescribing information provided for dosing and administration. The medication should be dispensed with the enclosed Medication Guide to each patient. The product was manufactured by Natco Pharma Limited in Parawada, India.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 4mg 21capsules)

This text provides information about a medication with the active ingredient Pomalidomide 4 mg. The manufacturer is Natco Pharma Limited in India. The storage conditions, standard dosage guidance, and important warnings regarding potential birth defects are also included. Additionally, it mentions a Medication Guide for patients and provides details such as NDC number, GTIN, serial number, lot number, and expiration date for quality control purposes. Overall, this text serves as relevant information for medical professionals and pharmacists regarding this specific medication.*

FDA Label Image

Figure-1 (Pomalidomide Capsules Figure 1)

FDA Label Image

Figure-2 (Pomalidomide Capsules Figure 2)

FDA Label Image

Structure (Pomalidomide Capsules Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.